301 related articles for article (PubMed ID: 6370406)
1. Biology and biochemistry of platelet-activating factor.
O'Flaherty JT; Wykle RL
Clin Rev Allergy; 1983 Sep; 1(3):353-67. PubMed ID: 6370406
[No Abstract] [Full Text] [Related]
2. Platelet-activating factor.
Pinckard RN
Hosp Pract (Off Ed); 1983 Nov; 18(11):67-76. PubMed ID: 6414941
[TBL] [Abstract][Full Text] [Related]
3. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
5. Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction.
Vargaftig BB
Agents Actions Suppl; 1983; 13():155-71. PubMed ID: 6575594
[TBL] [Abstract][Full Text] [Related]
6. Background and present status of research on platelet-activating factor (PAF-acether).
Vargaftig BB; Chignard M; Benveniste J; Lefort J; Wal F
Ann N Y Acad Sci; 1981; 370():119-37. PubMed ID: 7023317
[No Abstract] [Full Text] [Related]
7. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.
O'Donnell M
Ann N Y Acad Sci; 1991; 629():416-8. PubMed ID: 1659287
[No Abstract] [Full Text] [Related]
8. Species differences in platelet aggregation induced by platelet-activating factor (PAF).
Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Ou M; Mori T
Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):663-5. PubMed ID: 1294855
[TBL] [Abstract][Full Text] [Related]
9. [Antagonists of platelet activating factor].
Tokumura A; Tsukatani H
Seikagaku; 1985 Dec; 57(12):1618-23. PubMed ID: 3009656
[No Abstract] [Full Text] [Related]
10. Calcium-induced platelet aggregation in washed platelets from guinea pigs.
Miyamae T; Oshima K; Morikawa T; Hagiwara M
Pharmacology; 1995 Sep; 51(3):180-5. PubMed ID: 7501704
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.
Yamada T; Saito M; Mase T; Hara H; Nagaoka H; Murase K; Tomioka K
Lipids; 1991 Dec; 26(12):1179-83. PubMed ID: 1668114
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological properties of YM264, a potent and orally active antagonist of platelet-activating factor.
Yamada T; Tomioka K; Saito M; Horie M; Mase T; Hara H; Nagaoka H
Arch Int Pharmacodyn Ther; 1990; 308():123-36. PubMed ID: 2099131
[TBL] [Abstract][Full Text] [Related]
13. Platelet-tissue interaction: role of platelet-activating factor (PAF-acether).
Vargaftig BB; Chignard M; Lefort J; Benveniste J
Agents Actions; 1980 Dec; 10(6):502-6. PubMed ID: 7270336
[TBL] [Abstract][Full Text] [Related]
14. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
15. [Platelet-activating factor and antihypertensive polar renomedullary lipid: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine].
Masugi F; Ogihara T; Kumahara Y
Tanpakushitsu Kakusan Koso; 1982 Aug; 27(10):1342-7. PubMed ID: 6758041
[No Abstract] [Full Text] [Related]
16. [Platelet-activating factor producing cell--target cell interactions].
Oda M; Satouchi K; Saito K; Ikeda I
Rinsho Byori; 1989 Apr; Spec No 81():9-15. PubMed ID: 2754814
[No Abstract] [Full Text] [Related]
17. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
18. Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1992 Sep; 107(1):73-7. PubMed ID: 1330167
[TBL] [Abstract][Full Text] [Related]
19. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
[TBL] [Abstract][Full Text] [Related]
20. Potential role of platelet-activating factor in renal pathophysiology.
Camussi G
Kidney Int; 1986 Feb; 29(2):469-77. PubMed ID: 3517457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
